Georg W. Holzer - Concepedia

Author

Georg W. Holzer

Baxter (Austria)

Also Known As

G W Holzer, G. Holzer, G. W. Holzer, G.W. Holzer, Georg Holzer, Georg W Holzer, Georg W. Holzer

Publications

641

Citations

H-Index

Concepts

All Affiliations

Baxter (Austria)

About

Georg W. Holzer is an author at Baxter (Austria) specializing in medicine, virology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	397
2	Cell Biology	4	4	171
3	Allergy	2	2	133
4	Natural Sciences	1	1	52
5	Biology	1	1	22

Georg W. Holzer

Publications

586

Citations

H-Index

Page 1

	Year	Citations
A Tick-borne Encephalitis Virus Vaccine Based on the European Prototype Strain Induces Broadly Reactive Cross-neutralizing Antibodies in Humans Klaus K. Orlinger, Yvonne Hofmeister, Richard Fritz, The Journal of Infectious Diseases VaccinationVaccine DevelopmentAllergyMedicineVaccine Target	2011	104
Replicative retroviral vectors for cancer gene therapy Sounkary Solly, Stéphane Trajcevski, Charlotte Frisén, Cancer Gene Therapy Gene TherapiesViral ReplicationVirologyCancer Gene TherapyGene Vector	2002	80
Construction of a vaccinia virus deficient in the essential DNA repair enzyme uracil DNA glycosylase by a complementing cell line Georg W. Holzer, Falko G. Falkner Journal of Virology Viral ReplicationVirus DefectiveSynthetic VirologyGlycobiologyImmunology	1997	52
Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity Annett Hessel, Michael G. Schwendinger, Georg W. Holzer, PLoS ONE	2011	51
Human IgG Subclasses:<i>In Vitro</i>Neutralization of and<i>In Vivo</i>Protection against West Nile Virus Yvonne Hofmeister, Christina B. Planitzer, Maria R. Farcet, Journal of Virology	2010	40
Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection Georg W. Holzer, Sogué Coulibaly, Gerald Aichinger, Vaccine VaccinationVaccinologyVaccine DevelopmentImmunologyVirology	2011	36
Highly Efficient Induction of Protective Immunity by a Vaccinia Virus Vector Defective in Late Gene Expression Georg W. Holzer, G. Remp, G. Antoine, Journal of Virology	1999	36
A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations Annett Hessel, Michael G. Schwendinger, D. Fritz, PLoS ONE	2010	31
Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever Birgit Schäfer, Georg W. Holzer, Alexandra Joachimsthaler, PLoS ONE	2011	31
Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection Josef Mayrhofer, Sogué Coulibaly, Annett Hessel, Journal of Virology Viral PathogenesisImmunologyImmunotherapyCross-protectionVaccine Target	2009	29

Page 1